Thyroid transcription factor-1: Immunohistochemical evaluation in pulmonary neuroendocrine tumors

Citation
Al. Folpe et al., Thyroid transcription factor-1: Immunohistochemical evaluation in pulmonary neuroendocrine tumors, MOD PATHOL, 12(1), 1999, pp. 5-8
Citations number
12
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
Journal title
MODERN PATHOLOGY
ISSN journal
08933952 → ACNP
Volume
12
Issue
1
Year of publication
1999
Pages
5 - 8
Database
ISI
SICI code
0893-3952(199901)12:1<5:TTFIEI>2.0.ZU;2-R
Abstract
Thyroid transcription factor-1 (TTF-1), a nuclear transcription protein sel ectively expressed in the thyroid, the diencephalon, and respiratory epithe lium, is expressed in more than 90% of pulmonary small cell carcinomas (SCL Cs) and in almost 75% of pulmonary non-small cell carcinomas (NSCLCs), but it is absent in typical pulmonary carcinoids (TCs). Therefore, it was thoug ht that SCLC and NSCLC might share a common lineage, different from that of TC. TTF-1 expression in atypical pulmonary carcinoids (ACs) and large-cell neuroendocrine carcinomas (LCNECs) was not studied previously. We examined TTF-1 expression in 51 TCs, 9 ACs, 8 LCNECs, and 21 SCLCs with use of form alin-fixed material and heat-induced epitope retrieval. TTF-1 expression wa s seen in 18 (35%) of 51 TCs, all of the 9 ACs, 6 (75%) of the 8 LCNECs, an d 20 (95%) of the 21 SCLCs, These results reinforce earlier findings of the excellent sensitivity of TLF-l for SCLC, and they show similar sensitivity for AC and LCNEC, but they argue against the hypothesis that SCLC and TC a re of different cell lineages. The ubiquity of TTF-1 expression in pulmonar y NECs demonstrated in this study also argues against its use in their subc lassification.